Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
about
Insights into the key roles of proteoglycans in breast cancer biology and translational medicineEpithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?The motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans.17β-estradiol ameliorates age-associated loss of fibroblast function by attenuating IFN-γ/STAT1-dependent miR-7 upregulation.Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.Heparan sulfate and heparanase as modulators of breast cancer progressionIGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM moleculesCarbohydrate-containing molecules as potential biomarkers in colon cancer.Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.Syndecans as modulators and potential pharmacological targets in cancer progression.Shed proteoglycans in tumor stroma.Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression.Matrix pathobiology-central roles for proteoglycans and heparanase in health and disease.Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis.
P2860
Q28085548-737CC828-A0D9-4F4C-818B-7DAF154D3610Q28087055-C403E3DE-4FF2-4156-8910-636E21683C68Q34031745-AC0D957F-B206-4CB8-B5DF-0682614B1B60Q34516423-E0F6F058-3742-4D65-A531-50B3981416BDQ36947703-D3315E41-06FB-4763-8ECA-97D72094A661Q37105315-DAF3C5D1-FFEF-4DDA-BBF7-F704CE3EAC66Q37581720-56FDEBE6-3E14-4AE2-BC3E-E7A70675F0EFQ37686168-FBC17311-C3C8-46E7-B955-30118D1D83BCQ37717157-D7CC7324-3A0C-40BB-A0D2-68963CD74A51Q38189392-506E17DB-3D89-4AE2-9FAA-DE8C2CF28917Q38882752-DDC4EB6A-6FF3-48E3-BEE6-F6419C018E04Q47756248-A1FFA6B3-0A63-4BCD-AD95-B087C5184046Q51200400-D507185D-7D7C-46CA-8642-DE498148FE30Q53081280-56744E51-9E9E-4C02-9D3D-E60BD71032C4Q53171362-C6956598-8F1B-450A-A3F5-C704CA59B5D9
P2860
Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Evaluation of the coordinated ...... tility in breast cancer cells.
@en
Evaluation of the coordinated ...... tility in breast cancer cells.
@nl
type
label
Evaluation of the coordinated ...... tility in breast cancer cells.
@en
Evaluation of the coordinated ...... tility in breast cancer cells.
@nl
prefLabel
Evaluation of the coordinated ...... tility in breast cancer cells.
@en
Evaluation of the coordinated ...... tility in breast cancer cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Evaluation of the coordinated ...... otility in breast cancer cells
@en
P2093
Achilleas D Theocharis
Anastasios I Tsonis
Chrisostomi Gialeli
George N Tzanakakis
Maria-Ioanna Ellina
Spyridon S Skandalis
P2860
P304
P356
10.1111/FEBS.12162
P407
P577
2013-02-27T00:00:00Z